Alcon’s Travatan Ad Comparisons To Xalatan, Lumigan Are Misleading, FDA Says
This article was originally published in The Pink Sheet Daily
Executive Summary
FDA’s Division of Drug Marketing, Advertising & Communications cites a Travatan promotional card for unsubstantiated comparison claims in an "untitled" letter.